Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE
Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE
Abstracts 4. Gemeinsamer Jahreskongress der ... - SWISS KNIFE
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
swissknife spezial 06 12.06.2006 13:39 Uhr Seite 49<br />
(p=0.003), and 36% vs 25% in younger patients, respectively (p=0.025). In none of these<br />
analyses the method of revascularization, i.e. open surgical versus endovascular procedure,<br />
was associated with outcome.<br />
Conclusion: Revascularization significantly improves the prognosis of CLI at any age.<br />
Attempts to re-establish a sufficient circulation are therefore mandatory even in patients of 80<br />
years or ol<strong>der</strong>. However, no significant differences were found with respect to the choice of<br />
method of revascularization in this series for this age group.<br />
30.03<br />
P. Tozzi 1 , E. Borghi 2 , B. Perrin 3 , G. Siniscalchi 4 , E. Haesler 5 , D. Hayoz 5 , L.K. von Segesser 6<br />
1 Chirurgie Cardiovasculaire, CHUV, 1011 Lausanne/CH, 2 Engineering, Idee & Sviluppo, Bologna/IT,<br />
3 Cardiovascular Surgery, CHUV, Lausanne/CH, 4 Chirurgie Cardiovasculaire, CHUV,<br />
1011 Lausanne/CH, 5 Angiologie, CHUV, Lausanne/CH, 6 Chirurgie Cardiovasculaire, CHUV,<br />
1011 Lausanne/CH<br />
Edge-to-edge vascular repair: a new technique to improve long term anastomosis patency<br />
rate<br />
Objective: The suture technique described more than 100 years ago by Carrel still provides<br />
the best long term results in terms of anastomosis patency, with respect to other suture and<br />
sutureless techniques. Several sutureless anastomosis devices have been designed to facilitate<br />
the surgeon’s work but, almost in all cases, they have failed to reproduce the same long<br />
term results. The Vascular Join (VJ) is a sutureless vascular anastomosis device that has<br />
been designed and developed in our institution to facilitate the anastomosis construction and<br />
eventually improve its patency rate. We designed an animal study to assess its reliability and<br />
long-term efficacy and we report the preliminary results.<br />
Methods: Device description: VJ allows the construction of end-to-end and end-to-side anastomoses.<br />
It consists of two metallic crowns fixed to the extremity of the two conduits so that vessel<br />
edges are joined layer by layer. There is no foreign material exposed to blood. Animal<br />
model: in adult sheep, 45 to 55 kg, equipped with femoral arterial line, both carotid arteries<br />
were prepared and severed. After injection of heparin 100 U/kg, end-to-end anastomoses<br />
were performed using the VJ device on one side and the classical running suture technique<br />
with 6-0 prolene on the other side. Carotid blood flow was measured with Medistim probe.<br />
Animal received aspirin 100 mg/day and were followed-up with Duplex-scan every 3 months<br />
and sacrificed after 12 months. Hystopathological analysis was carried out.<br />
Results: Sixteen animals were enrolled and all survived the procedure. A total of 16 sutureless<br />
anastomeses were successfully completed in less than 2 minutes versus 6±3 min for running<br />
suture. Mean post operative carotid flow was 180±46 ml/min on the sutureless side and<br />
163±36 ml/min in the control side. Duplex showed the occlusion at 3 months of 3 controls<br />
and one sutureless anastomosis. 2 controls and 1 sutureless had stenosis >50% at 12<br />
months. Histology showed very thin layer of myointimal hyperplasia (50±10 mm) in the sutureless<br />
group versus 300±27 mm in the control. No significant inflammatory reaction was<br />
detected.<br />
Conclusion: VJ provides edge-to-edge vascular repair that can be consi<strong>der</strong>ed the most physiological<br />
way to restore vessel continuity. For the first time, in an animal study with long term<br />
follow up, an anastomotic device provided better results than suture technique. Clinical trial is<br />
about to start to validate these results.<br />
30.04<br />
H. Probst 1 , F. Huot 2 , S. Déglise 3 , C. Haller 4 , L. Mazzolai 5 , F. Saucy 1 , F. Bosman 6 , J. Corpataux 7<br />
1 Service De Chirurgie Thoracique et Vasculaire, Centre Hospitalier Universitaire Vaudois, 1011<br />
Lausanne/CH, 2 Bioengineering, MachineVision, 1011 Lausanne/CH, 3 1012 Lausanne/CH,<br />
4 Thoracic and Vascular Surgery, CHUV, 1011 Lausanne/CH, 5 Service D'angiologie, Centre Hospitalier<br />
Universitaire Vaudois, 1011 Lausanne/CH, 6 Institut De Pathologie, Centre Hospitalier<br />
Universitaire Vaudois, 1011 Lausanne/CH, 7 Vascular and Thoracic Surgery, CHUV, 1011<br />
Lausanne/CH<br />
Comparative assessment of continuous and pulsatile ex-vivo perfusion of human saphenous<br />
vein after 14 days<br />
Objective: Vessel wall trauma induces vascular remodeling, as intimal hyperplasia (IH) and<br />
subse-quent thrombotic occlusions, compromising vascular reconstructions. Plasminogen<br />
activator system might precociously induce a prothrombotic state in the vein graft associated<br />
with stenosis development. Ex-vivo perfusion of human vessel segments is a well-suited setting<br />
to assess venous segments regarding vessel wall remodeling and fibrinolytic alterations.<br />
Methods: The ex-vivo vein support system (EVVSS) consists of an incubator containing a perfusion<br />
chamber and a gearing pump. This setting allows to perfuse vessel segments with a<br />
continous flow un<strong>der</strong> low shear stress conditions. This perfusion system modified to produce<br />
pulsatile flow by an arbitrary waveform generator controlled by computer is un<strong>der</strong> high shear<br />
stress conditions. Both systems maintain a constant perfusate temperature (37°C±0.l°C),<br />
pCO2 (35-45mmHg), pO2 (90-110mmHg) and pH (7.41±0.05). Human saphenous vein<br />
segments are perfused in both settings un<strong>der</strong> constant conditions (pressure, flow, shear<br />
stress) during 14 days. We performed computer-assisted histomorphometry, immunohistochemistry<br />
(CD 31, CD 34, Factor VIII, MIB 1, alpha-actin) and expression of fibrinolytic factor<br />
(t-PA, u-PA and PAI-l by Northern blot) before and after perfusion on each segment.<br />
Results: Nine human saphenous vein segments were perfused for 14 days, with respect of<br />
their morphological integrity. Histomorphometry revealed significant IH development in the<br />
continuous perfusion system after 14 days. No IH development was observed in the pulsatile<br />
system. Expression of CD31, CD34 and alpha actin was demonstrated in all segments after<br />
culture and perfusion indicating muscular and endothelial integrity in both groups. We observed<br />
an upregulation of PAI-1 in both settings after 14 days.<br />
Conclusion: Vessel wall integrity is maintained in the ex-vivo continuous and pulsatile flow<br />
perfusion. The continuous flow is a valid setting for the assessment of IH un<strong>der</strong> standardized<br />
conditions. The pulsatile flow conditions inhibits IH development un<strong>der</strong> high shear stress conditions.<br />
30.05<br />
A. Assadian, C. Senekowitsch, G.W. Hagmüller<br />
I. Chirurgie, Wilhelminenspital Vienna, A-1160 Vienna/AT<br />
Prevalence of patients continuing to smoke after vascular interventions<br />
Objective: Smoking is one of the most important risk factors for the development and progression<br />
of atherosclerosis. Smoking cessation presents an obligatory element in the manage-<br />
ment of vascular patients and also in patients scheduled for vascular interventions. The aim<br />
of this study was to assess the prevalence of patients smoking before and after vascular surgical<br />
procedures and to evaluate the requirements for inpatient smoking cessation programs<br />
and nicotine replacement therapy.<br />
Methods: 500 patients admitted for vascular interventions were included in this prospective<br />
study. Smoking status was evaluated as well as measurements of exhaled breath CO;<br />
patients had to answer a standardized Fagerström questionnaire on admission and after surgery<br />
to identify current smokers and to quantify nicotine dependency, respectively.<br />
Results: of 500 patients included, only 70 (14%) never had smoked, 243 (49 %) had quit<br />
smoking before admission and 161 (32%) were current smokers. of the current smokers 64<br />
(40%) did not smoke during hospitalization. 97 (60%) current smokers continued to smoke<br />
in hospital. of these patients, 78 patients (80%) were male and 19 female; the mean age was<br />
61 ± 4 years (range 40 84 years). 4 patients had surgery of infra-renal aortic aneurysm, 40<br />
patients had carotid endarterectomy and 53 patients had PAD. There was no difference between<br />
abstinent patients and continuing smokers concerning previous cigarette consumption<br />
or Fagerström score, a predictor for long term smoking behavior. Patients with carotid artery<br />
stenosis were significantly more abstinent while hospitalized (P=0.006). Patients with PAD,<br />
however, were more likely to continue smoking as inpatients (P=0.004). 65% of continuing<br />
smokers stated that they would stop smoking in hospital if counseling and nicotine replacement<br />
therapy would be provided. Regarding their predominant location of atherosclerosis,<br />
patients with PAD were less willing to quit smoking while hospitalized compared to patients<br />
with carotid stenosis (53% vs 88%, respectively; P < 0.001).<br />
Conclusion: A substantial fraction of patients admitted for vascular surgery are smokers.<br />
More than half of these continue to smoke in the hospital, an environment where smoking is<br />
prohibited by law. Counseling, nicotine replacement therapy as well as smoking cessation<br />
programs for vascular surgical inpatients is urgently needed.<br />
30.06<br />
S. Déglise 1 , C. Haller 2 , H. Probst 3 , S.D. Qanadli 4 , J. Corpataux 3<br />
1 1012 Lausanne/CH, 2 Thoracic and Vascular Surgery, CHUV, 1011 Lausanne/CH, 3 Vascular<br />
and Thoracic Surgery, CHUV, 1011 Lausanne/CH, 4 Radiology, CHUV, 1011 Lausanne/CH<br />
Is the use of the great saphenous vein a suitable alternative for arteriovenous fistulas creation<br />
in the upper limb?<br />
Objective: Failure or non-maturation of arteriovenous fistulas for haemodialysis access<br />
remains relatively frequent although preoperative assessment of forearm superficial venous<br />
system has been developped. Moreover, increasing the prevalence of arteriovenous fistula<br />
over synthetic graft is critical for decreasing the morbidity of these patients. Therfeore, the<br />
great saphenous vein could be an alternative when no suitable veins exist on the arm.<br />
Methods: Between August 2000 and September 2003, 12 patients un<strong>der</strong>went arteriovenous<br />
fistulas creation on the forearm for haemodialysis access. They were 10 men and 2 women<br />
with a mean age of 58 years (range 35-80). In all these patients but 2, one or more arteriovenous<br />
fistula had been previously created and failed. Data were reviewed to analyze the evolution<br />
of these fistulas in terms of blood flow, stenosis or patency rates.<br />
Results: The technical success was 92% (11/12) because in one patient, the fistula was<br />
rapidly oc-cluded leading to the use of a dialysis catheter. The mean blood flow measured in<br />
the 11 matured fistulas was 836 ml/min. In 5 patients, 12 stenoses occurred during the follow-up,<br />
the first stenosis appearing on average after 10 months. Seven (58%) of them were<br />
succesfully treated by angioplasty. Two surgical revisions were also necessary and in the 3<br />
remaining cases, a new prostethic fistula was created. Moreover, 2 occluded fistulas were<br />
successfully treated by surgical thrombectomy and one dilated fistula justifyied its surgical replacement.<br />
One patient with an occluded fistula died due to gastrointestinal sepsis. Overall<br />
primary, assisted primary and secondary patency rates were 33%, 42% and 50% respectively.<br />
Conclusion: The use of a saphenous vein for arteriovenous fistulas creation on the forearm<br />
seems to show low patency rates and high frequency of complications especially stenosis.<br />
Therefore, this procedure should be kept in reserve only for very specific conditions as presence<br />
of infection.<br />
30.07<br />
H.O. Savolainen 1 , J. Schmidli 2 , F. Dick 3 , I. Bau mgartner 2 , M. Mohaupt 4<br />
1 Vascular Surgery, Swiss Cardiovascular Center, 3010 Bern/CH, 2 Swiss Cardiovascular<br />
Centre, Uni-versity Hospital, Bern/CH, 3 Swiss Cardiovascular Centre, University Hospital, 3010<br />
Bern/CH, 4 Departement of Nephrology, University Hospital, Bern/CH<br />
Determinants of hemodialysis access survival<br />
Objective: Vascular access patency is vital for patients requiring hemodialysis. Various factors<br />
interfere with access patency. This analysis is projected to validate potential risk factors<br />
and benefits including unintended impact of co-medication.<br />
Methods: Hemodialysis access procedures between January 1999 and December 2001<br />
were retro-spectively analysed. Clinical data and concomitant medication were retrieved from<br />
files as were surgical data following a standardized data capture sheet. Minimal required follow-up<br />
with functioning access was 2 years.<br />
Results: During the observation period, 244 vascular accesses were created (60.7% male<br />
patients, 36.1% pre-emptive) with 102 remaining primarily patent. Censored (death, transplantation,<br />
access termination) primary (PP) and secondary patency (SP) was 5<strong>4.</strong>6% and<br />
71.7%, respectively, at 540 days. Patency of permanent cuffed catheters was lowest due to<br />
censoring events. Diabetes mellitus reduced PP (p